Literature DB >> 25209355

Test-retest reliability of the English version of the Edinburgh Postnatal Depression Scale.

Jocelyn Kernot1, Tim Olds2, Lucy K Lewis2, Carol Maher2.   

Abstract

Test-retest reliability of the English version of the Edinburgh Postnatal Depression Scale (EPDS) has not been established. This study aimed to address this gap in psychometrics by examining test-retest reliability in a sample of 118 Australian mothers with babies aged under 12 months, with a mean of 2.82 (SD 1.38) days between test occasions. The EPDS was found to have a high level of test-retest reliability for total scores (ICC = 0.92) and PND risk categories (90.7 % agreement).

Entities:  

Mesh：

Year:  2014        PMID： 25209355     DOI： 10.1007/s00737-014-0461-4

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN： 1434-1816            Impact factor:   3.633


  18 in total

1.  Self-Care for Health in Rural Hispanic Women at Risk for Postpartum Depression.

Authors:  Younglee Kim; Vivien Dee
Journal:  Matern Child Health J       Date:  2017-01

2.  Maternal mental health during the neonatal period: Relationships to the occupation of parenting.

Authors:  Rachel Harris; Deanna Gibbs; Kathryn Mangin-Heimos; Roberta Pineda
Journal:  Early Hum Dev       Date:  2018-04-04       Impact factor: 2.079

3.  Towards Preventative Psychiatry: Concurrent and Longitudinal Predictors of Postnatal Maternal-Infant Bonding.

Authors:  Frances L Doyle; Sophie J Dickson; Valsamma Eapen; Paul J Frick; Eva R Kimonis; David J Hawes; Caroline Moul; Jenny L Richmond; Divya Mehta; Mark R Dadds
Journal:  Child Psychiatry Hum Dev       Date:  2022-05-26

4.  Association Between Maternal Adverse Childhood Experiences and Neonatal SCG5 DNA Methylation-Effect Modification by Prenatal Home Visiting.

Authors:  Alonzo T Folger; Nichole Nidey; Lili Ding; Hong Ji; Kimberly Yolton; Robert T Ammerman; Katherine A Bowers
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

5.  Digilego for Peripartum Depression: A Novel Patient-Facing Digital Health Instantiation.

Authors:  Alexandra Zingg; Deevakar Rogith; Jerrie S Refuerzo; Sahiti Myneni
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

6.  Combinations of adverse childhood events and risk of postpartum depression among mothers enrolled in a home visiting program.

Authors:  Nichole Nidey; Katherine Bowers; Robert T Ammerman; Anita N Shah; Kieran J Phelan; Margaret J Clark; Judith B Van Ginkel; Alonzo T Folger
Journal:  Ann Epidemiol       Date:  2020-10-01       Impact factor: 3.797

7.  Prevalence and risk factors of postpartum depression, general depressive symptoms, anxiety and stress (PODSAS) among mothers during their 4-week postnatal follow-up in five public health clinics in Perak: A study protocol for a cross-sectional study.

Authors:  Saidatul Akmar Mohammad Redzuan; Priyasini Suntharalingam; Thenmoli Palaniyappan; Venotha Ganasan; Puteri Normalina Megat Abu Bakar; Paream Kaur; Lili Zuryani Marmuji; Subashini Ambigapathy; V Paranthaman; Boon How Chew
Journal:  BMJ Open       Date:  2020-06-21       Impact factor: 2.692

8.  The comorbidity of low back pelvic pain and risk of depression and anxiety in pregnancy in primiparous women.

Authors:  Rosa Virgara; Carol Maher; Gisela Van Kessel
Journal:  BMC Pregnancy Childbirth       Date:  2018-07-04       Impact factor: 3.007

9.  Are we validly assessing major depression disorder risk and associated factors among mothers of young children? A cross-sectional study involving home visitation programs.

Authors:  Arthur H Owora; Hélène Carabin; Tabitha Garwe; Michael P Anderson
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

10.  Adapting and testing a brief intervention to reduce maternal anxiety during pregnancy (ACORN): study protocol for a randomised controlled trial.

Authors:  Esther L Wilkinson; Heather A O'Mahen; Pasco Fearon; Sarah Halligan; Dorothy X King; Geva Greenfield; Jacqueline Dunkley-Bent; Jennifer Ericksen; Jeannette Milgrom; Paul G Ramchandani
Journal:  Trials       Date:  2016-03-22       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.